Pam2CSK4/ODN-M362 / Pulmotect 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pam2CSK4/ODN-M362 / Pulmotect
2018-002806-30: A study in patients with Chronic Obstructive Pulmonary Disease (COPD) to see if a new medicine under development (PUL-042) can prevent symptoms and effects on the lungs when the patient is deliberately infected with a virus (rhinovirus) that causes the common cold.

Not yet recruiting
2
24
Europe
PUL-042, Concentrate for nebuliser solution
Pulmotect, Inc., Pulmotect, Inc.
GOLD (Global Initiative for Chronic Obstructive Lung Disease) stage 0 Chronic Obstructive Pulmonary Disease (COPD), Emphysema, chronic bronchitis, and refractory (non-reversible) asthma. The disease is characterized by increasing breathlessness., Diseases [C] - Respiratory Tract Diseases [C08]
 
 

Download Options